SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis

Cell Cycle
Minakshi NihalGary S Wood

Abstract

Silent information regulator type-1 (SIRT1) is the best-studied member of the Sirtuin (Sir2) family of nicotinamide dinucleotide (NAD)-dependent class III histone deacetylases (HDACs), but has not yet been explored in cutaneous T-cell lymphoma (CTCL). We analyzed five CTCL cell lines and lesional tissues using flow cytometry, immunostaining, immunoblotting, cell death, viability, and apoptosis assays, small-molecule inhibitors, and shRNA knockdown. We found strong SIRT1 expression among CTCL lines relative to normal lymphocytes. CTCL cells in lesional tissues also expressed SIRT1 strongly. SIRT1 knockdown resulted in reduced cellular metabolism and proliferation, increased apoptosis, and PARP cleavage products. Tenovin-1, which reversibly inhibits class III HDACs (SIRT1 and SIRT2), reduced SIRT enzymatic activity and SIRT1 expression and led to increased apoptosis. These alterations were accompanied by increased forkhead box O3 (FoxO3) in several cell lines and increased nuclear p53, as well as acetylated p53 in wtp53 MyLa CTCL line. A combination of class I/II and class III HDACIs (vorinostat and tenovin-1) produced significantly greater growth inhibition, cell death via apoptosis, as well as superior p53 promoter upregulation...Continue Reading

References

Oct 1, 1990·Molecular and Cellular Biology·J Cheng, M Haas
Dec 4, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M H VermeerR Willemze
Aug 17, 2004·Trends in Cell Biology·Maria E Giannakou, Linda Partridge
Apr 28, 2007·The Cancer Journal·Janice M Mehnert, Wm Kevin Kelly
Jun 28, 2007·Expert Opinion on Investigational Drugs·Madeleine Duvic, Jenny Vu
Jul 25, 2007·Journal of Cell Science·Haojie Huang, Donald J Tindall
Oct 16, 2007·Oncogene·K L RiceJ D Licht
Aug 30, 2008·The American Journal of Surgical Pathology·Kyu Yun JangWoo Sung Moon
Sep 9, 2008·Biochemical and Biophysical Research Communications·Barbara Zschoernig, Ulrich Mahlknecht
Jan 29, 2009·International Journal of Biological Sciences·Chu-Xia Deng
Apr 17, 2009·The Journal of Investigative Dermatology·E Contassot, Lars E French
Jul 31, 2009·Oncogene·J Yu, L Zhang
Jan 19, 2010·Cell Cycle·Anna E Johnsson, Anthony P H Wright
May 14, 2010·Cold Spring Harbor Perspectives in Biology·David P LaneSonia Lain
Nov 3, 2010·Archives of Biochemistry and Biophysics·Jianqiang WuGary S Wood
Dec 15, 2010·Journal of Biomedicine & Biotechnology·Alessia Peserico, Cristiano Simone
Jan 5, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Yolanda OlmosEric W-F Lam
Jan 29, 2011·Journal of Gastrointestinal Cancer·Günter SchneiderDieter Saur
Sep 1, 2011·Handbook of Experimental Pharmacology·Astrid HagelkruysChristian Seiser
Sep 24, 2011·Genes & Cancer·Laia Bosch-Presegué, Alejandro Vaquero
Feb 10, 2012·Frontiers in Pharmacology·Vincenzo CarafaLucia Altucci
Feb 11, 2012·International Journal of Cancer. Journal International Du Cancer·Tomohiro KozakoShinji Soeda
Mar 6, 2012·The British Journal of Dermatology·B LamprechtS Mathas
Mar 8, 2012·Nature Reviews. Molecular Cell Biology·Riekelt H HoutkooperJohan Auwerx
Mar 16, 2012·Future Medicinal Chemistry·Sophia RangwalaMadeleine Duvic
Mar 31, 2012·Clinical Journal of Oncology Nursing·Robin FryeSusan Booher
Apr 27, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·H Miles Prince, Michael Dickinson
Aug 14, 2012·Journal of the American Academy of Dermatology·Nathalie StutzGary S Wood
Aug 28, 2012·Cellular & Molecular Immunology·Xin ZhangQuan-Xing Wang
Sep 13, 2012·The Annals of Pharmacotherapy·Miryoung KimCindy L O'Bryant
Sep 25, 2012·Cellular & Molecular Biology Letters·Paweł Hikisz, Zofia M Kiliańska
Dec 19, 2012·Journal of the American Academy of Dermatology·Sara SamimiEllen Kim

❮ Previous
Next ❯

Citations

Oct 24, 2014·Cell Death & Disease·L MaB Brodin
Jul 21, 2015·Cancer Biology & Therapy·Pranjal SarmaManika Pal Bhadra
Oct 5, 2015·Dermatologic Clinics·Gary S Wood, Jianqiang Wu
Nov 7, 2014·Frontiers in Oncology·Johanna PflaumMartina Müller
Aug 16, 2016·Biochemical and Biophysical Research Communications·Elizabeth H Cho, Yan Dai
Apr 11, 2018·Journal of Cardiothoracic Surgery·Ming-Chun MaShau-Hsuan Li
May 16, 2019·Journal of Zhejiang University. Science. B·Fei-Teng HuangLing Li
Jan 17, 2015·Current Opinion in Oncology·Jennifer A DeSimoneEmmanuella Guenova
Apr 11, 2014·International Journal of Molecular Medicine·Gang DuZicheng Li
May 3, 2019·Cell Death & Disease·Neelum Aziz YousafzaiXian Wang
Nov 5, 2019·Archives of Dermatological Research·Jingkai XuYaohua Zhang
Dec 15, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Claudia Cs ChiniEduardo N Chini
Aug 22, 2014·Molecular Cancer Research : MCR·Lijia ZhuYan Dai
Jan 14, 2021·International Journal of Molecular Sciences·Ewa Maria KratzAgnieszka Piwowar
Mar 3, 2021·Journal of Cellular and Molecular Medicine·Adele ChimentoVincenzo Pezzi
Apr 4, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Gagan ChhabraNihal Ahmad
Jul 13, 2021·Frontiers in Oncology·Ping Zhang, Mingzhi Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis